Bird & Bird advised Fonds Patient Autonome and Uniqa Ventures on their €4 million financing round of Fizimed

International law firm Bird & Bird advised Fonds Patient Autonome, managed by Bpifrance, and Uniqa Ventures on their participation in the €4 million financing round of Fizimed, a femtech dedicated to women's health.

The Fonds Patient Autonome and Uniqa Ventures led the financing round, in which UI Investissement also participated.

The Bird & Bird team advising Fonds Patient Autonome and Uniqa Ventures comprised of partner Carole Bodin and associate Pascaline Sagot, who advised on the corporate aspects, with partner Alexandre Vuchot and associate Caroline Arrighi-Savoie advising on the regulatory aspects.

The company was advised by Charles Russell Speechlys. The team comprised of partner Renaud Ferry and Counsel Orlando Vignoli Neto.

News & Deals

More News & Deals
News Bird & Bird Advises Smart Digital Group as Singapore Counsel on Nasdaq Listing

May 22 2025

Read More
Deal Bird & Bird advises City & Guilds on sale of the Kineo group to Mind Tools

May 21 2025

Read More
News Bird & Bird opening office in Riyadh, Saudi Arabia

May 20 2025

Read More
Deal Bird & Bird advises MirSense on its €7 million fundraising

May 19 2025

Read More
News Bird & Bird named most active clean energy legal adviser in the Clean Energy League Table 2025

May 19 2025

Read More
Deal Bird & Bird Advises Voyc on $2 Million Seed Funding Round

May 14 2025

Read More